Guardant Health
GH
#3559
Rank
HK$24.06 B
Marketcap
HK$195.58
Share price
-1.18%
Change (1 day)
-8.80%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -HK$3.84 B

According to Guardant Health 's latest financial reports the company's current earnings (TTM) are -HK$3.83 B. In 2023 the company made an earning of -HK$3.74 B an increase over its 2022 earnings that were of -HK$5.1 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$3.84 B2.7%
2023 -HK$3.74 B-26.73%
2022 -HK$5.1 B69.96%
2021 -HK$3 B56.35%
2020 -HK$1.92 B252.69%
2019 -HK$0.55 B-17.22%
2018 -HK$0.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$2.27 B-40.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.12 B-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA